Enhanced TDS
Knowde-enriched technical product data sheet
Identification & Functionality
- Food Ingredients Functions
- Pharma & Nutraceuticals Functions
Features & Benefits
- Benefit Claims (Health)
Applications & Uses
- Markets
Properties
Technical Details & Test Data
- Clinical Data
- CURSOL is a patented active ingredient offering highly soluble curcumin with powerful anti-inflammatory action.
- CURSOL is particularly designed for all pathologies involving inflammatory processes. Its highly free-flowing powder form allows any possible mixture with other active ingredients for targeting a selected pathology.
- There is a real need for natural and side-effects-free anti-inflammatory ingredients with high security of use and level of activity. Numerous anti-inflammatory drugs present a lot of side effects and cannot be administrated for chronic use. CURSOL is thus a natural alternative to the classical NSAID's drugs.
- Taking CURSOL on a chronic basis will achieve a steady state of curcumin in the plasma. This will prevent inflammatory processes.
- CURSOL contains a highly soluble curcumin extract (Curcuma longa L.) in a patented formulation involving food-grade emulsifiers that increase significantly its assimilation.
- Its active principle acts on the symptoms of all inflammatory pathologies, caused by numerous diseases (for example ostheoarthritis, gastrointestinal disorders) to relieve:
- Joint pain and cartilage degradation,
- Abdominal pain (troubles associated with intestinal disorders)
- Due to the excellent safety profile of the active ingredient, CURSOL can safely be taken on a chronic basis.
- Cursol Is Delivered With a Complete Package of Information, Including Bioxtract Proprietary
- Pre-clinical in vitro efficacy trial evaluating the action on chondrocytes and cartilage inflammation,
- Pre-clinical acute oral toxicity trial in rats showing no particular effect and classifying the product in the danger 5 category DL50 superior 5,000 mg/kg,
- Comparative study of CURSOL's solubility to the major Curcumin formulations available on the market in the same conditions.
- Phase I clinical trial, assessing the higuer bioavailability of CURSOL in comparison to Meriva® (lecitin formulation from the company INDENA).